Structural and functional alterations in MRI-negative drug-resistant epilepsy and associated gene expression features

Area of Science:

• Neuroimaging
• Epilepsy Research
• Genetics

Background:

• Epilepsy research frequently employs neuroimaging, yet MRI-negative drug-resistant epilepsy (DRE) structural/functional changes and their genetic underpinnings are unclear.
• Understanding these mechanisms is crucial for developing targeted treatments for DRE.

Purpose of the Study:

• To investigate structural and functional brain alterations in DRE patients using MRI.
• To explore the genetic mechanisms associated with drug resistance in epilepsy.

Main Methods:

• Structural and functional MRI scans were used to analyze gray matter volume (GMV) and regional homogeneity (ReHo) in DRE, drug-sensitive epilepsy (DSE), and healthy control groups.
• Gene expression data from the Allen human brain atlas were correlated with GMV/ReHo findings.
• Real transcriptional data from blood samples were compared with identified gene expression patterns.

Main Results:

• Significant structural and functional alterations were observed in the cerebellum of DRE patients.
• These cerebellar changes in DRE patients are potentially linked to the mechanisms of drug resistance.
• Abnormal gene expression related to nervous system development was associated with observed brain morphology and activity changes in DRE.

Conclusions:

• Cerebellar alterations in DRE may play a role in drug resistance.
• Changes in brain morphology and regional activity in DRE patients are linked to aberrant gene expression.
• The transcription factor SP1 is implicated as a key player in the mechanisms of drug resistance in epilepsy.